3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
2
Suspended
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
1
Interventions
Specimen Handling
9
Magnetic Resonance Spectroscopy
7
Biopsy
6
Nivolumab
4
Capecitabine
4
Bevacizumab
4
Radiosurgery
3
Paclitaxel
3
Irinotecan
3
Fluorouracil
3
Everolimus
3
Docetaxel
3
Cyclophosphamide
3
Cisplatin
3
trifluridine tipiracil drug combination
2
spartalizumab
2
pembrolizumab
2
lenvatinib
2
decitabine and cedazuridine drug combination
2
daratumumab
2
Vincristine
2
Taxes
2
Radiation
2
Prednisone
2
Pemetrexed
2
Oxaliplatin
2
Mitoxantrone
2
Leucovorin
2
Etoposide
2
Epirubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Suspended
×
Riluzole
×
Clear all
NCT03722680
2026-05-20
RILUZOX-01
UNICANCER
Phase 2
Suspended
80 enrolled